Impax Asset Management Group »

Vertex Pharmaceuticals Incorporated shares owned by Impax Asset Management Group

Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Impax Asset Management Group from 13F filings

Historical chart of Impax Asset Management Group investment in Vertex Pharmaceuticals Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Vertex Pharmaceuticals Incorporated held by Impax Asset Management Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by Impax Asset Management Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.8M 4.6k 391.64
2025-06-30 $2.1M 4.6k 445.20
2025-03-31 $3.4M 7.0k 484.82
2024-12-31 $2.8M 6.9k 402.70
2024-09-30 $3.5M 7.4k 465.08
2024-06-30 $25M 53k 468.72
2024-03-31 $28M 68k 418.01
2023-12-31 $34M 84k 406.89
2023-09-30 $194M 558k 347.10
2023-06-30 $205M 584k 351.29
2023-03-31 $240M 762k 314.47
2022-12-31 $220M 764k 288.24
2022-09-30 $202M 698k 289.00
2022-06-30 $203M 721k 281.79
2022-03-31 $225M 861k 260.97
2021-12-31 $227M 1.0M 219.60
2021-09-30 $195M 1.1M 181.39
2021-06-30 $152M 756k 201.63
2021-03-31 $19M 89k 214.89
2020-12-31 $18M 76k 236.34
2020-09-30 $18M 65k 272.12
2020-06-30 $14M 47k 290.31
2020-03-31 $13M 53k 237.95
2019-12-31 $9.8M 45k 218.95
2019-09-30 $7.5M 44k 169.42
2019-06-30 $846k 4.6k 183.36
2019-03-31 $767k 4.2k 183.93
2018-12-31 $575k 3.5k 165.85
2018-09-30 $656k 3.4k 192.88

More positions owned by Impax Asset Management Group

Linde Common Stock (LIN)
Microsoft Corp Common Stock (MSFT)
Xylem Common Stock (XYL)
NVIDIA Corp Common Stock (NVDA)
Veralto Corp Common Stock (VLTO)
Hubbell Common Stock (HUBB)
Pentair Common Stock (PNR)
Aptiv Common Stock (APTV)
Agilent Technologies Common Stock (A)
A O Smith Corp Common Stock (AOS)
Advanced Drainage Systems Common Stock (WMS)
IDEX Corp Common Stock (IEX)
RenaissanceRe Holdings Common Stock (RNR)
Synopsys Common Stock (SNPS)
Marvell Technology Common Stock (MRVL)

View all positions for Impax Asset Management Group

Top funds holding Vertex Pharmaceuticals Incorporated

Capital World Investors
Vanguard Group
BlackRock
Capital Research Global Investors
State Street Corporation
Jpmorgan Chase & Co
Geode Capital Management
Wellington Management Company
Capital Research and Management Company - Division 3
Alliancebernstein
Loomis, Sayles and
Jennison Associates
Morgan Stanley
FMR
Ubs Global Asset Management Americas

View all funds holding Vertex Pharmaceuticals Incorporated